source
- NIH now allows businesses to apply for its research fundingThe National Institutes of Health announced that companies are eligible to submit grant applications, expanding the pool of potential research partners. This change aims to foster collaboration bet…
- Connect Biopharma's asthma drug rademikibart misses primary endpoint in Phase 2 trialConnect Biopharma reported that its IL-4/IL-13 blocker rademikibart failed to meet the primary endpoint in a Phase 2 study in asthma patients with type-2 inflammation. The trial enrolled 160 patie…